Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant

References

• Shigematsu A, Tanaka J, Suzuki R, et al. Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia. Int J Hematol 2011;94:463–471.
   PubMed Web of Science ®Google Scholar
• Gupta T, Kannan S, Dantkale V, et al. Cyclophosphamide plus total body irradiation compared with busulfan plus cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in patients with leukemia: a systematic review and meta-analysis. Hematol Oncol Stem Cell Ther 2011;4:17–29.
   PubMedGoogle Scholar
• Fefer A, Einstein AB, Thomas ED, et al. Bone-marrow transplantation for hematologic neoplasia in 16 patients with identical twins. N Engl J Med 1974;290:1389–1393.
   PubMed Web of Science ®Google Scholar
• Tutschka PJ, Copelan EA, Klein JP. Bone marrow transplantation for leukemia following a new busulfan and cyclophosphamide regimen. Blood 1987;70:1382–1388.
   PubMed Web of Science ®Google Scholar
• Santos GW, Tutschka PJ, Brookmeyer R, et al. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide. N Engl J Med 1983;309:1347–1353.
   PubMed Web of Science ®Google Scholar
• Goldstone AH, Rowe JM. Transplantation in adult ALL. Hematology Am Soc Hematol Educ Program 2009:593–601.
   Google Scholar
• Pasquini MC, Wang Z, Horowitz MM, et al. 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone marrow disorders. Clin Transpl 2010:87–105.
   Google Scholar
• Przepiorka D, Weisdorf D, Martin P, et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995;15:825–828.
   Google Scholar
• Mori T, Aisa Y, Kato J, et al. Safety and efficacy of total body irradiation, cyclophosphamide, and cytarabine as a conditioning regimen for allogeneic hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Am J Hematol 2012;87:349–353.
   PubMed Web of Science ®Google Scholar
• Marks DI, Forman SJ, Blume KG, et al. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission. Biol Blood Marrow Transplant 2006;12:438–453.
   PubMed Web of Science ®Google Scholar
• Clift RA, Buckner CD, Appelbaum FR, et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens. Blood 1990;76:1867–1871.
   PubMed Web of Science ®Google Scholar
• Cornelissen JJ, van der Holt B, Verhoef GE, et al. Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison. Blood 2009;113:1375–1382.
   PubMed Web of Science ®Google Scholar
• Ribera JM, Oriol A, Bethencourt C, et al. Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial. Haematologica 2005;90:1346–1356.
   PubMed Web of Science ®Google Scholar
• Hahn T, Wall D, Camitta B, et al. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults:an evidence-based review. Biol Blood Marrow Transpl 2006;12:1–30.
   PubMed Web of Science ®Google Scholar
• Ferry C, Socié G. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia: what have we learned?. Exp Hematol 2003;31:1182–1186.
   PubMed Web of Science ®Google Scholar
• Ringden O, Labopin M, Tura S, et al. A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Br J Haematol 1996;93:637–645.
   PubMed Web of Science ®Google Scholar
• Granados E, de La Camara R, Madero L, et al. Hematopoietic cell transplantation in acute lymphoblastic leukemia:better long term eventfree survival with conditioning regimens containing total body irradiation. Haematologica 2000;85:1060–1067.
   PubMed Web of Science ®Google Scholar
• Kiehl MG, Kraut L, Schwerdtfeger R, et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol 2004;22:2816–2825.
   PubMed Web of Science ®Google Scholar
• Kalaycio M, Bolwell B, Rybicki L, et al. BU- vs TBI-based conditioning for adult patients with ALL. Bone Marrow Transplant 2011;46:1413–1417.
   PubMed Web of Science ®Google Scholar
• Shi-Xia X, Xian-Hua T, Hai-Qin X, et al. Total body irradiation plus cyclophosphamide versus busulphan with cyclophosphamide as conditioning regimen for patients with leukemia undergoing allogeneic stem cell transplantation: a meta-analysis. Leuk Lymphoma 2010;51:50–60.
   PubMed Web of Science ®Google Scholar